129 related articles for article (PubMed ID: 38509654)
1. Reirradiation of metastases of the central nervous system: part 1-brain metastasis.
Rades D; Simone CB; Wong HCY; Chow E; Lee SF; Johnstone PAS
Ann Palliat Med; 2024 Mar; ():. PubMed ID: 38509654
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery.
Kim DH; Schultheiss TE; Radany EH; Badie B; Pezner RD
J Neurooncol; 2013 Oct; 115(1):37-43. PubMed ID: 23813230
[TBL] [Abstract][Full Text] [Related]
3. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
[TBL] [Abstract][Full Text] [Related]
4. Tumor control and incidence of radiation necrosis after reirradiation with stereotactic radiosurgery for brain metastases.
Terakedis BE; Jensen RL; Boucher K; Shrieve DC
J Radiosurg SBRT; 2014; 3(1):21-28. PubMed ID: 29296381
[TBL] [Abstract][Full Text] [Related]
5. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
6. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
7. Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity.
Fritz C; Borsky K; Stark LS; Tanadini-Lang S; Kroeze SGC; Krayenbühl J; Guckenberger M; Andratschke N
Front Oncol; 2018; 8():551. PubMed ID: 30524969
[No Abstract] [Full Text] [Related]
8. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.
El Shafie RA; Dresel T; Weber D; Schmitt D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Eichkorn T; Adeberg S; Debus J; Rieken S; Bernhardt D
Front Oncol; 2020; 10():693. PubMed ID: 32477942
[No Abstract] [Full Text] [Related]
9. Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival.
Patel M; Siddiqui F; Jin JY; Mikkelsen T; Rosenblum M; Movsas B; Ryu S
J Neurooncol; 2009 Apr; 92(2):185-91. PubMed ID: 19066727
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases.
Hirata M; Yasui K; Oota N; Ogawa H; Onoe T; Maki S; Ito Y; Hayashi K; Asakura H; Murayama S; Mitsuya K; Deguchi S; Nakamura K; Hayashi N; Nishimura T; Harada H
Radiat Oncol; 2022 Dec; 17(1):213. PubMed ID: 36578021
[TBL] [Abstract][Full Text] [Related]
11. Reirradiation of brain metastases with radiosurgery.
Maranzano E; Trippa F; Casale M; Costantini S; Anselmo P; Carletti S; Principi M; Caserta C; Loreti F; Giorgi C
Radiother Oncol; 2012 Feb; 102(2):192-7. PubMed ID: 21880387
[TBL] [Abstract][Full Text] [Related]
12. Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts.
Li J; He J; Cai L; Lai M; Hu Q; Ren C; Wen L; Wang J; Zhou J; Zhou Z; Li S; Ye M; Shan C; Chen L; Zhou C
Ann Palliat Med; 2021 Feb; 10(2):2018-2026. PubMed ID: 33549015
[TBL] [Abstract][Full Text] [Related]
13. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
14. Management approach for recurrent brain metastases following upfront radiosurgery may affect risk of subsequent radiation necrosis.
Rae A; Gorovets D; Rava P; Ebner D; Cielo D; Kinsella TJ; DiPetrillo TA; Hepel JT
Adv Radiat Oncol; 2016; 1(4):294-299. PubMed ID: 28740900
[TBL] [Abstract][Full Text] [Related]
15. Stereotatic radiosurgery of 468 brain metastases < or =2 cm: implications for SRS dose and whole brain radiation therapy.
Shehata MK; Young B; Reid B; Patchell RA; St Clair W; Sims J; Sanders M; Meigooni A; Mohiuddin M; Regine WF
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):87-93. PubMed ID: 15093903
[TBL] [Abstract][Full Text] [Related]
16. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
[TBL] [Abstract][Full Text] [Related]
17. Radionecrosis after repeated courses of radiotherapy under stereotactic conditions for brain metastases: Analysis of clinical and dosimetric data from a retrospective cohort of 184 patients.
Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Cox DG; Bund C; Antoni D; Cebula H; Noel G
Cancer Radiother; 2022 Sep; 26(5):692-702. PubMed ID: 35715354
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
[TBL] [Abstract][Full Text] [Related]
19. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
[TBL] [Abstract][Full Text] [Related]
20. Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysis.
Palmer JD; Perlow HK; Matsui JK; Ho C; Prasad RN; Liu K; Upadhyay R; Klamer B; Wang J; Damante M; Ghose J; Blakaj DM; Beyer S; Grecula J; Arnett A; Thomas E; Chakravarti A; Lonser R; Hardesty D; Prevedello D; Prabhu R; Elder JB; Raval RR
J Neurooncol; 2022 Sep; 159(2):389-395. PubMed ID: 35751740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
